ReviewJournal of virology2026
Human infection with pseudorabies virus: review of evidence, risk assessment, and future directions.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated Analysis of Chromatin Accessibility and Transcriptional Dynamics of the Viral Genome Following Pseudorabies Virus Infection.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Pseudorabies virus (PRV) is an alphaherpesvirus with a broad host range, with the pig as its natural host. Although PRV can use human cell surface receptors for cell entry, humans and higher primates have been considered as refractory or showing very limited susceptibility to PRV infection. Between 1914 and 2011, only 17 cases of suspected human PRV infection were described, typically displaying temporal and mild/intermediate disease symptoms, mostly consisting of severe itching. No neurological complications were reported. In addition, in 1970, one researcher conducted a repetitive PRV self-inoculation experiment, which resulted in neither symptoms nor seroconversion. However, since 2011 and mostly based on next-generation sequencing on cerebrospinal fluid, 34 human cases of suspected PRV infection have been reported, all of which were linked with severe, life-threatening encephalitis and/or visual impairment. All these cases were reported in China, where there has been a concomitant surge in outbreaks of PRV strains that show genetic differences compared to classical PRV strains. All suspected recent cases of human PRV infection had (occupational) contact with raw pig meat and often had skin damage on the hands or fingers, or direct eye contact with potentially PRV-infected material. Importantly, human-to-human PRV infection has never been reported. Although the risk for human PRV infection remains very low, these recent developments should guide increased efforts to eradicate PRV from domestic pig populations, increase protection of individuals at risk, and increase research on improved diagnostics, effective antivirals, and a better understanding of the host and viral factors that determine human susceptibility or resistance to PRV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.